Tandem Diabetes Care to Announce Second Quarter 2023 Financial Results on August 3, 2023
10 Julho 2023 - 5:05PM
Business Wire
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin
delivery and diabetes technology company, plans to release its
second quarter 2023 results after the financial markets close on
Thursday, August 3, 2023. The Company will hold a conference call
and simultaneous webcast on the same day at 4:30 pm Eastern Time
(1:30 pm Pacific Time), to discuss its second quarter 2023
financial and operating results.
A live webcast of the call will be available on Tandem Diabetes
Care’s Investor Center website located at
http://investor.tandemdiabetes.com in the “Events &
Presentations” section. To access the call by phone, please use
this link
(https://register.vevent.com/register/BIb61cfe435b0f43f5a67b990141f26d3d)
and you will be provided with dial-in details, including a personal
pin.
An archive of the webcast will be available for 30 days
following the event on Tandem Diabetes Care’s Investor Center
website located at http://investor.tandemdiabetes.com in the
“Events & Presentations” section.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc., a global insulin delivery and
diabetes technology company based in San Diego, California, creates
new possibilities for people living with diabetes, their loved
ones, and healthcare providers through a positively different
experience. The Company’s human-centered approach to design,
development, and support delivers innovative products and services
for people who use insulin. Tandem manufactures and sells the
t:slim X2 insulin pump with Control-IQ technology. For more
information, visit tandemdiabetes.com.
Tandem Diabetes Care and Control-IQ are trademarks registered in
the U.S. and/or other countries and t:slim X2 is a trademark of
Tandem Diabetes Care, Inc.
Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use
#tslimX2 and #TandemDiabetes. Follow Tandem Diabetes Care on
Facebook at www.facebook.com/TandemDiabetes. Follow Tandem Diabetes
Care on LinkedIn at
https://www.linkedin.com/company/tandemdiabetes.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230710098997/en/
Media Contact: 858-255-6388 media@tandemdiabetes.com
Investor Contact: 858-366-6900 IR@tandemdiabetes.com
Tandem Diabetes Care (NASDAQ:TNDM)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Tandem Diabetes Care (NASDAQ:TNDM)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024